关键词：分子诊断业务；核酸检测段；PCR技术
摘 要：The Molecular Diagnostics segment is one of the fastest growing segments in the Diagnostics market and it is expected to reach over US$ 8.1 billion by 2017. The Nucleic Acid Testing segment is one of the fastest growing segments in the Molecular Diagnostics segment. Over two decades, PCR has dominated as the standard tool for detection in blood transfusion, genetic testing, and other disorders. However, the changes in the industry outlook toward a cost - effective, rapid, and reliable means of detection have posed a limitation on the usage of PCR. This has led to a spurt of novel technologies collectively known as INAAT. INAAT is a technique/technology in which the nucleic acid is amplified under isothermal conditions. Due to its inherent features, INAAT holds promise for bringing nucleic acid testing to field settings with its ease-of-use and portable or instrument-free detection.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Application

07.1.1 Infectious Disease Diagnostics

07.1.2 Blood Screening

07.1.3 Laboratory Research

07.1.4 Cancer Research

07.2 Global INAAT Market for Infectious Disease

Diagnostics

07.2.1 Market Size and Forecast

07.3 Global INAAT Market for Blood Screening

07.3.1 Market Size and Forecast

07.4 Global INAAT Market for Laboratory Research

07.4.1 Market Size and Forecast

07.5 Global INAAT Market for Cancer Research

07.5.1 Market Size and Forecast

08. Market Segmentation by Technology

08.1.1 NASBA

08.1.2 LAMP

08.1.3 SDA

08.1.4 TMA

08.1.5 SPIA

08.1.6 HDA

08.1.7 Others

09. Comparative Analysis of Top INAAT

10. Geographical Segmentation

10.1 INAAT Market in the Americas

10.1.1 Market Size and Forecast

10.2 INAAT Market in the EMEA Region

10.2.1 Market Size and Forecast

10.3 INAAT Market in the APAC Region

10.3.1 Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Acquisitions

18.2 Vendor Analysis 2013

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 Becton, Dickinson and Co.

19.1.1 Business Overview

19.1.2 Business Segmentation

19.1.3 Key Information

19.1.4 SWOT Analysis

19.2 bioMérieux S.A.

19.2.1 Business Overview

19.2.2 Key Information

19.2.3 SWOT Analysis

19.3 Hologic Inc.

19.3.1 Business Overview

19.3.2 Business Segmentation

19.3.3 Key Information 8

19.3.4 SWOT Analysis

19.4 Novartis International AG

19.4.1 Business Overview

19.4.2 Business Segmentation

19.4.3 Key Information

19.4.4 SWOT Analysis

19.5 Quidel Corp.

19.5.1 Business Overview

19.5.2 Key Information

19.5.3 SWOT Analysis

20. Other Reports in this Serie